News

February 6, 2024

The Lipshutz Lab would like to congratulate Staff Research Associate Taryn Diep on her accepted oral presentation. Out of 175 submitted abstracts to the 2024 Society for Inherited Metabolic Disorders (SIMD) Conference, Taryn’s abstract – centered on the dysmyelination of Arginase deficiency, has been selected as one of only six oral presentations. Congratulations on this accomplishment Taryn!... Read More

June 4, 2023

The Lipshutz Lab would like to congratulate Staff Research Associate Lizzie Zhang for her achievements and her acceptance to the University of Virginia’s Neuroscience Graduate Program. Thank you for all your contributions to this lab!... Read More

June 4, 2023

The Lipshutz Lab would like to congratulate Staff Research Associate Colleen Le for her achievements and her acceptance into UCLA David Geffen School of Medicine. Thank you for all of your contributions to this lab!... Read More

June 4, 2023

Lizzie Zhang and Dr. Gerry Lipshutz presented at this year’s ASGCT Conference. Lizzie presented “Oligodendrocyte Toxicity by Guanidino Compounds, Not Arginine, Fosters Dysmyelination in Arginase Deficiency and is Prevented by AAV-Based Gene Therapy.” Dr. Lipshutz presented “mRNA-3927 Therapy for Propionic Acidemia: Interim Data From a Phase 1/2 Study.” Congratulations to both Lizzie and Dr. Lipshutz!... Read More

February 17, 2023

Dr. Gerald Lipshutz has been awarded the Quest Award by the California Institute for Regenerative Medicine (CIRM)! The $2.3 million award will fund the lab’s work to develop a one-time gene therapy to treat creatine transporter deficiency, which inhibits creatine—a molecule that is an essential energy source for brain and muscle cells—from reaching the brain and muscles and causes neural…... Read More